This expert consultation study (n=12) investigated the exclusion of individuals with personal or familial histories of psychopathological experiences from most psychedelic clinical trials and treatment programs. Experts in psychiatry, clinical psychology, medicine, and psychedelics were interviewed, and the findings revealed that exclusion criteria may be justified in studies with minimal psychological support. They agreed that psychedelic-assisted psychotherapy, as well as therapy with MDMA and ketamine, might be beneficial for some individuals within this group.
- Published
- Journal
- International Journal of Mental Health and Addiction
- Authors
- La Torre, J. T., Mahammadli, M., Faber, S., Greenway, K. T., Williams, M. T., Abbate, V.